Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$202M |
| 2 |
BLD
TopBuild
BLD
|
+$181M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$156M |
| 4 |
New York Times
NYT
|
+$112M |
| 5 |
Insight Enterprises
NSIT
|
+$54.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKQ Corp
LKQ
|
+$246M |
| 2 |
Citigroup
C
|
+$143M |
| 3 |
SLM Corp
SLM
|
+$52.2M |
| 4 |
Bausch Health
BHC
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.7% |
| 2 | Financials | 30.57% |
| 3 | Real Estate | 10.83% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 3.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FISV
1
Fiserv Inc
FISV
$28B
| $1.3B | 20.77% |
14,647,776
+1,612,575
| +12% | +$156M |
|
|
2
KKR & Co
KKR
$97.4B
| $1.22B | 19.52% |
26,456,563
+3,851,214
| +17% | +$202M |
|
3
Seagate
STX
$193B
| $960M | 15.3% |
13,437,070
| – | – |
|
4
CBRE Group
CBRE
$44B
| $680M | 10.83% |
9,234,964
+2,355
| +0% | +$190K |
|
|
5
LKQ Corp
LKQ
$6.52B
| $616M | 9.82% |
12,552,751
-4,997,660
| -28% | -$246M |
|
|
6
Citigroup
C
$221B
| $506M | 8.06% |
10,992,637
-2,853,470
| -21% | -$143M |
|
|
7
Insight Enterprises
NSIT
$4.33B
| $354M | 5.64% |
4,099,226
+556,083
| +16% | +$54.3M |
|
|
BLD
8
DELISTED
TopBuild
BLD
| $201M | 3.21% |
1,204,908
+990,537
| +462% | +$181M |
|
|
9
SLM Corp
SLM
$4.97B
| $174M | 2.77% |
10,886,031
-3,015,000
| -22% | -$52.2M |
|
|
10
Bausch Health
BHC
$2.41B
| $120M | 1.91% |
14,341,265
-89,636
| -0.6% | -$1.25M |
|
|
11
New York Times
NYT
$10.6B
| $86.4M | 1.38% |
+3,095,000
| New | +$112M |
|
|
AMPS
12
DELISTED
Altus Power
AMPS
| $25.2M | 0.4% |
4,000,020
+20
| +0% | +$134 |
|
13
Rocket Companies
RKT
$39.4B
| $14.7M | 0.23% |
+2,000,000
| New | +$17.3M |
|
|
UNVR
14
DELISTED
Univar Solutions Inc.
UNVR
| $8.46M | 0.13% |
+340,000
| New | +$10M |
|
15
Trinity Industries
TRN
$2.37B
| $2.2M | 0.04% |
90,847
| – | – |
|
|
AMPS.WS
16
DELISTED
Altus Power Warrants
AMPS.WS
| $24K | ﹤0.01% |
18,417
| – | – |
|
Similar funds
Mason Morfit's Q2 2022 Portfolio in Review
As of Q2 2022, Mason Morfit held 16 positions worth $6.27B, down 14% from $7.27B the previous quarter. Its ten largest holdings account for 98% of the portfolio.
Mason Morfit deployed $291M of net new capital in Q2 2022, opening 3 new positions and adding to 6 existing holdings. Its largest new stake was New York Times: 3,095,000 shares worth $86.4M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 40% a quarter earlier, followed by Financials and Real Estate.
On the sell side, the largest reduction was LKQ Corp, an estimated $246M trimmed.
- Mason Morfit's largest Q2 2022 buy was New York Times: 3,095,000 shares worth $86.4M.
- Mason Morfit added most to KKR & Co in Q2 2022, an estimated $202M increase.
- Mason Morfit's biggest Q2 2022 reduction was LKQ Corp, cutting an estimated $246M.
- Mason Morfit's ten largest holdings make up 98% of its $6.27B portfolio in Q2 2022.
- Mason Morfit opened 3 new positions and closed 0 in Q2 2022.
- Mason Morfit's portfolio value fell 14% quarter-over-quarter to $6.27B.
Based on ValueAct Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.